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ABSTRACT 27 
Background:  Although podoconiosis is endemic in Cameroon, little is known about its 28 
epidemiology and spatial distribution.  29 
Methods: In this cross-sectional, population-based study, we enrolled all adults (≥15 years) 30 
residing in the districts of North-West Region of Cameroon for more than 10 or more years. 31 
Participants were interviewed, had physical examination. The study outcomes were prevalence 32 
estimates lymphoedema and podoconiosis. House-to-house screening was conducted by 33 
Community Health Implementers (CHIs). CHIs registered all individuals with lymphoedema and 34 
collected additional individual and household-related information. A panel of experts re-examined 35 
and validated all lymphoedema cases registered by CHIs.  36 
Results: Of the 439,781 individuals registered, 214,195 were adults (≥15 years old) and had lived 37 
in the districts of the Region for more than 10 years. A total of 2,143 lymphoedema cases, were 38 
identified by CHIs, giving a prevalence of lymphoedema 1.0% (95% confidence interval [CI]; 39 
0.96-1.04) (2,143/214,195). After review by experts, podoconiosis prevalence in the study area 40 
was 0.48% (1,049/214,195) (95% CI; 0.46-0.52). The prevalence of podoconiosis varied by health 41 
district, from 0.16% in Oku to 1.92% in Bafut (p < 0.05). A total of 374 patients were recruited by 42 
stratified random sampling from the validated CHIs’ register to assess the clinical features and 43 
socio-economic aspects of the disease. Patients reportedly said to have first noticed swelling at an 44 
average age of 41.9 ± 19.1 (range: 6-90 years). Most patients (86.1%) complained of their legs 45 
suddenly becoming hot, red and painful. The majority (309, 96.5%) of the interviewees said they 46 
had worn shoes occasionally at some point in their life. The reportedly mean age at first shoe 47 
wearing was 14.2 ± 10.1 (± Standard Deviation), range (1-77 years). A high proportion (82.8%) 48 
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of the participants wore shoes at the time of interview. Of those wearing shoes, only 67 (21.7%) 49 
were wearing protective shoes.  50 
Conclusion: This study provides insight into the geographical distribution and epidemiology of 51 
podoconiosis in the North West region of Cameroon, yet management is limited. Evidence-52 
informed targeted interventions are needed to manage people with lymphoedema.  53 
Keywords: non-filarial lymphoedema; podoconiosis; spatial distribution; epidemiology; 54 
Cameroon 55 
 56 
BACKGROUND 57 
Lymphoedema of the lower limbs is a consequence of localized fluid retention resulting from a 58 
compromised lymphatic system [1]. In Africa, it is mostly driven by a nematode (roundworm) 59 
parasites of the family Filariodidea (Wuchereria bancrofti), whose adult forms obstruct the 60 
lymphatic system, leading to the swelling of a limb or other tissue [2]. Another form of 61 
lymphoedema, called podoconiosis, occurs in volcanic highland zones of Africa due to prolonged 62 
exposure to certain soil chemicals. This form of lymphoedema mostly affects individuals who do 63 
not wear shoes regularly since childhood. 64 
Podoconiosis has also been reported from southeast Asia and Central and South America [3].  In 65 
Africa, the disease has been identified in at least 18 countries, including; Angola, Burundi, 66 
Cameroon, Cape Verde, Chad, Democratic Republic of Congo, Equatorial Guinea, Ethiopia, 67 
Kenya, Madagascar, Mozambique, Niger, Nigeria, Rwanda, São Tomé and Príncipe, Sudan, 68 
Tanzania, and Uganda.[3].  69 
5 
 
Previous studies have documented the association of the disease with irritant red clay soils, which 70 
are generated in areas over 1,000 meters above sea level (m.a.s.l.), with 1,000 mm annual rainfall 71 
and maximum temperatures of 200C [4]. High concentrations of phyllosilicate clays (smectite and 72 
kaolinite) and mica groups, quartz (crystalline silica), iron oxide, and zirconium have been 73 
described in high prevalence areas of northern Ethiopia [5]. Additionally, the genetic heritability 74 
to the disease has been confirmed, and specific genetic associations with susceptibility to disease 75 
have been demonstrated [6, 7].  76 
The distribution of podoconiosis in the North West Region of Cameroon is not clearly understood, 77 
in spite of the few studies conducted in this area [8-10]. Mapping is important to design successful 78 
control and prevention measures [11, 12]. Information collected through mapping surveys is 79 
important for planning, monitoring, and evaluation of control programmes [13-17]. 80 
The objective of this study was to determine the spatial distribution and epidemiology of 81 
podoconiosis in the Northwest Region of Cameroon. This was done with the involvement of 82 
trained Community Health Implementers (CHIs), who have proven to be capable of clinically 83 
identify podoconiosis patients with acceptable positive predictive value after thorough training 84 
[18]. The findings will enable implementation of a scheme for podoconiosis-related lymphoedema 85 
management in the study area.  86 
  87 
6 
 
METHODS 88 
Study area 89 
This study included all the 19 health districts of the North West Region of Cameroon. Podoconiosis 90 
had previously been demonstrated in some of these health districts [10], and was suspected across 91 
large parts of the region. The North West region is mostly hilly with a mean altitude of 1,403 m 92 
above sea level. It experiences two seasons (dry and wet) with a mean annual rainfall of 2,500 mm 93 
[18]. The very fertile soils in the region are used to grow rice, maize, beans and other vegetables 94 
[18]. Farming is therefore the main mean of subsistence and source of household income in the 95 
region.  96 
Study design 97 
A cross-sectional study was carried out to establish the spatial distribution, the profile and disease 98 
assessment for clinical and socio-economic aspects of podoconiosis in the North West Region.  99 
Prior to the study, the feasibility of using CHIs to screen for podoconiosis was tested and details 100 
of the methods used for training have been described elsewhere [18]. CHIs conducted house-to-101 
house clinical screening of lymphoedema cases within the communities in the study area whilst a 102 
team of supervisors simultaneously collected geographical coordinates and supervised CHIs’ 103 
work. A sample of confirmed podoconiosis cases were interviewed to measure preventive 104 
behaviours and potential economic loss due to the disease. 105 
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Training of research assistants and community health implementers 106 
Training was done in two phases both taking place in the North West region. Supervisors provided 107 
the first phase, and supervisors plus researchers the second phase.  Training on the disease, its 108 
causes, clinical manifestations, differential diagnosis, staging, treatment, prevention and socio-109 
economic impact took place at district hospitals. The training also focused on community 110 
sensitization and data recording. A practical exercise was conducted with either patients or 111 
photographs of the different podoconiosis stages including guidelines for their identification.  112 
Sampling strategy and study population 113 
A mixed sampling approach was used for the mapping exercise. All health areas in each of the 19 114 
health districts of the region were considered for mapping. Within each health area, systematic 115 
sampling was used to select 50-60% of communities within each health area.  A few communities 116 
(<0.01%) were not visited because they were inaccessible during the rainy season. All households 117 
within selected communities were surveyed. Within each household, individuals of both sexes, 118 
older than 15 years of age and who had lived in the area for at least 10 years were recruited. The 119 
CHIs visited registered individuals in all the households of the assigned quarter or zone and 120 
examined them for lymphoedema. Geographical coordinates of surveyed villages were taken at 121 
the centre of the community, most often at the chief’s place or a public space such as the market. 122 
A team of experienced researchers familiar with podoconiosis re-examined and validated all 123 
lymphedema cases registered by CHIs, following a differential diagnosis protocol published by 124 
Desta et al (2007)[6]. Therefore, anyone with lymphedema, as recorded by CHIs, was considered 125 
a suspected podoconiosis case, whereas confirmed podoconiosis cases were those with 126 
lymphedema of the lower legs with bilateral asymmetry who had no history or clinical signs of 127 
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lymphatic filariasis (LF), systematic disease, or leprosy and residing in the district for more than 128 
10 years[19].  129 
Podoconiosis clinical features and socio-economic assessment 130 
After the mapping exercise, a stratified random sampling approach was used to select a subsample 131 
of confirmed podoconiosis cases for more in-depth clinical and socio-economic assessment.  132 
All the validated cases were stratified by disease stages (stages 2, 3, 4 and 5) and by age. Based on 133 
total number within each disease category, patients were selected by proportion to represent about 134 
1/5 of the total affected population. Using a semi-structured questionnaire, socio-demographic data 135 
and information on shoe wearing habits, family history of the disease, disease morbidity, economic 136 
loss and patient mean monthly income, were collected. Patients’ earnings were estimated based on 137 
salaries for employed patients over the last month extrapolated to a calendar year plus the total 138 
annual agricultural products multiplied by average market price, to give an annual per patient sum. 139 
Monthly mean income per patient was then estimated from the annual income. Patients were asked 140 
to provide an estimate of their daily hours of work when sick and prior to developing podoconiosis, 141 
to estimate the number of productive days lost by patients due to illness. Patients were also 142 
clinically staged and examined for the presence of podoconiosis clinical features such as mossy 143 
changes, wounds, bilateral swelling and enlarged inguinal nodes. Clinical features were selected 144 
based on a previous study in Ethiopia [20], which included criteria such as being a long-term 145 
resident of a podoconiosis-endemic area and lower leg changes consistent with podoconiosis 146 
(bilateral but asymmetric leg involvement; swelling, mossy changes and/or nodules). Clinical 147 
staging was done according to Tekola et al. [21].  148 
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Data entry and analysis 149 
The census data were recorded in printed registers and then entered in a standardized database 150 
created in EpiInfo v.3.5.3 while geographical coordinates were collected in a Microsoft Excel 2013 151 
spreadsheet. Analysis of collected data was carried out using SPSS version 20 (Chicago, IL, USA). 152 
Crude prevalence was computed as the number of affected people in a health district divided by 153 
the total number of people registered, multiplied by 100. The Chi-squared test was used to compare 154 
prevalence data or proportions of individuals affected between health districts, age groups and by 155 
gender. Crude prevalence data (generated from CHIs’ case records) were adjusted using a factor 156 
determined by comparing CHIs’ and supervisors’ findings by health districts. The adjustment 157 
factor (positive predictive value) was defined as the ratio of total number of confirmed cases to the 158 
total number of suspected cases (present during the validation survey) and multiplied by 100. 159 
Adjusted prevalence data were then mapped using ArcGIS version 10.3 software.  160 
Descriptive statistics such as frequency tables and bar charts were used to determine the profile of 161 
podoconiosis cases by age group and gender, and prevalence by disease stages was calculated. The 162 
profile of clinical features with respect to disease stage was examined, and differences established 163 
using the chi-squared test. Patients’ preventive behaviours, acute attacks and economic loss were 164 
descriptively analysed. All the statistical tests were performed at a 5% significance level.  165 
Finally, to improve the visualization of spatial distribution of podoconiosis cases, we estimated 166 
the density of podoconiosis cases across North West region using a Kernel Density Estimator, 167 
which is a non-parametric way to estimate the probability density function of a random variable 168 
[22, 23]. We opted for applying a Gaussian function as density estimator, and results where fed 169 
into a spatial grid of 100 x 100 meters resolution. This analysis was implemented using in R v3.4.3 170 
using the splancs package and final map layouts made in ArcGIS version 10.3 software.  171 
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RESULTS 172 
Characteristics of study participants  173 
Of the 439,781 individuals registered, 214,195 were 15 years old or older and had stayed in the 174 
region for more than 10 years. The male/female ratio was 0.78. 2,143 people with lymphedema s 175 
were identified by CHIs, resulting in lymphoedema prevalence of 1.0% (2,143/214,195).The 176 
prevalence of podoconiosis was 0.48%, 95% CI [0.46-0.52]. The majority of health districts 177 
(16/19) had disease prevalence less than 1% (Table 1). 178 
Table 1: Lymphoedema and podoconiosis prevalence within Health Districts in North West 179 
Cameroon 180 
Health 
District 
Number 
of 
communit
ies  
surveyed 
Number of 
eligible 
screened 
15-10 
(years)* 
Lymphoed
ema cases 
 
Prevalence of 
lymphoedema 
(%) 
 
Prevalence of 
podoconiosis (%) 
95%CI** 
Ako 22 4288 24 0.56 0.27 [0.11-0.43] 
Bafut 39 9946 393 3.95 1.92 [1.65-2.19] 
Bali 25 3546 27 0.76 0.37 [0.17-0.57] 
Bamenda 53 26441 181 0.68 0.33 [0.26-0.40] 
Batibo 46 8934 303 3.39 1.64 [1.41-1.95]] 
Benakuma 19 4988 43 0.86 0.42 [0.24-0.60] 
Fundong 45 17579 91 0.52 0.25 [0.18-0.32] 
Kumbo 
East 
67 18624 129 0.69 0.33 [0.25-0.41] 
Kumbo 
West 
34 9509 48 0.5 0.24 [0.14-0.34] 
Mbengwi 43 8076 96 1.19 0.58 [0.41-0.75] 
Ndop 76 25605 232 0.9 0.44 [0.360.52] 
Ndu 34 9918 87 0.87 0.42 [0.29-0.55] 
Njikwa 12 1233 29 2.35 1.14 [0.55-1.73] 
Nkambe 49 12572 114 0.91 0.44 [0.320.56] 
Nwa 33 8215 61 0.74 0.36 [0.230.49] 
Oku 47 15911 55 0.34 0.16 [0.10-0.22] 
Santa 35 9449 125 1.32 0.64 [0.48-0.80] 
Tubah 34 8364 41 0.49 0.24 [0.140.34] 
Wum 60 10997 64 0.58 0.28 [0.18-0.38] 
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Total 773 214195 2143 1 0.49[0.46-0.52] 
*People who had more than 15 years and had stayed in the community for more than 10 
yrs.                                                      
**95% Confidence interval. 
 181 
Influence of sex and age on lymphoedema prevalence 182 
Of the 214,195 participants, lymphoedema was more prevalent among females (0.53%) than males 183 
(0.45%) (Table 2), when adjusted for age and duration of stay there was no significant difference 184 
between male and female (OR= 1.07; 95%CI [0.98– 1.16], p = 0.149]. The prevalence of 185 
lymphoedema increased with age for both sexes. People aged 50 years or above have 7.5 higher 186 
odds of lymphoedema risk than younger ones (< 30 years old) (OR= 7.5; 95%CI [6.33 – 8.98], p 187 
< 0.001).  188 
Table 2: Influence of sex and age on lymphoedema prevalence 189 
Variable Prevalence (%) Adjusted OR (95% CI) p-value 
Gender    
Male 1010 (0.47) 1.07 (0.98– 1.16) 0.149 
Female 1133 (0.53) Reference category NA 
Age Group    
<30 185 (0.09) Reference category  NA 
30-40 231 (0.11) 1.73 (1.43 – 2.11) <0.001 
40-50 315 (0.15) 2.88 (2.39 – 3.47) <0.001 
50 plus 1412 (0.66) 7.54 (6.33 – 8.98) <0.001 
NA: Not Applicable 190 
a Odds ratio was adjusted for sex, age and duration in community 191 
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We found evidence of interaction between age and sex (p<0.001) in their association with 192 
podoconiosis prevalence. Therefore stratified analysis (age-sex) presented. The prevalence of 193 
lymphoedema was shown to increase with age, and men aged 50 or older were more affected 194 
(Figure 1).  195 
Figure 1: Lymphoedema prevalence by sex and age in the North West Region. 196 
Lymphedema stages in the North-West 197 
Generally, lymphedema cases on early stages were more frequent than chronic cases. Of the 2,143 198 
lymphedema cases, the highest proportion was recorded on stage 2 (60.6%), followed by stage 3 199 
(25.7%) and stage 4 (11.5%). Stage 5 was the least common (2.2%). (Figure 2) 200 
Figure 2: Prevalence of lymphoedema stages in the North West Region. 201 
With an exception of stage 5, all lymphedema stages appeared to increase with age. Stage 2 and 202 
stage 5 were more prevalent within patients over 50 years old (Figure 2).  203 
Spatial distribution of podoconiosis in the North-West region 204 
Overall, in the 19 Health Districts of the North West region of Cameroon, 439,781 individuals 205 
were registered from 773 communities. Figure 3A shows the spatial distribution of the 206 
communities surveyed in the North-West region of Cameroon. This map shows some areas of the 207 
region that remained unsurvey. These areas correspond to dense forest that are uninhabited, such 208 
as Wum, Nkambe, Kumbo East, Ako, Fundong and Njikwa. The density map for confirmed 209 
podoconiosis cases (Figure 3B) is clearly showing four zones of high incidence in the southern 210 
part of the region, including the following health districts: Batibo, Bafut, Tubah, Ndop and parts 211 
of Mbengwi, Fundong, and Bamenda. There are areas at the north of the region, which either are 212 
environmentally unsuitable for the disease or its endemicity is estimated to be very low.  213 
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Figure 3: Distribution of surveyed communities and prevalence of podoconiosis in the 214 
North West Cameroon 215 
 216 
Table 1 shows the number of health districts and communities surveyed, number of individuals 217 
registered and the prevalence rate by health district. The prevalence varied between health districts 218 
from 0.16% in Oku to 1.92% in Bafut (p< 005). The disease was more prevalent in Bafut (1.92%), 219 
Batibo (1.64%) and Njikwa (1.14%) (Table 1).  220 
 221 
Characteristics of people with podoconiosis recruited subsequently for socio-economic and 222 
clinical assessment 223 
A total of 374 patients were recruited by stratified random sampling from the validated CHIs’ 224 
register to assess the clinical features and socio-economic aspects of the disease. Patients 225 
reportedly said to have first noticed swelling at an average age of 41.9 ± 19.1 (range: 6-90 years). 226 
Women noticed first swelling earlier (35.85 ± 16.5) than men (49.1 ± 20.2, p< 0.001) (Table 3). 227 
The average time patients had lived with the condition was 15.8 ± 14.9 years, (range: 1-72 years). 228 
This number of years was relatively higher (16.4 ± 14.7 years) in females than males (15 ± 15.1 229 
years, P= 0.42). A total of 134 (35.9%) selected cases declared to have or to have had at least 1 230 
person in the family with the affection (mean= 0.41 ± 0.6-person, range: 1-3, Table 3). Married 231 
individuals (86.1%) were significantly more affected than single individuals (13.9%). Farmers and 232 
people with no formal education were the most affected (Table 3). 233 
Table 3: Characteristics of sub-population with podoconiosis >15 years of age   234 
 Variable  Number (%) 
Gender   
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Female 206 (55.1) 
Male 168 (44.9) 
Marital status    
Married 322 (86.1) 
Single 52 (13.9) 
Occupation/Profession    
Farmer 255 (68.2) 
Other 65 (17.4) 
Unemployed 54 (14.4) 
Literacy   
No formal education 199 (53.2) 
Primary 145 (38.7) 
Secondary 27 (7.2) 
University 3 (0.8) 
Number of persons in the family with leg swelling, dead or alive, 
Mean (±SD) 
0.41 (±0.63) 
1 113 (84.3) 
2 15 (11.1) 
3 4( 2.9) 
Age (years) at first noticing swelling (N=368) Mean (±SD; Range) 41.8 (±19.4; 6-90) 
 
< 10 
11 (3.0) 
[10-20] 35 (9.5) 
[20-40] 124 (33.7) 
[40-60] 124 (33.7) 
> 60 74 (20.1) 
Duration in years with swelling (N= 370) Mean (±SD) 15.88 (±14.9)    
< 10 161 (43.8) 
[10-20] 81 (22.0) 
[20-40] 89 (24.2) 
[40-60] 32 (8,7) 
> 60 5 (1.4) 
 235 
 236 
Assessment of podoconiosis clinical features 237 
Of the 374 podoconiosis patients examined, 73.3% had bilateral lymphedema. The highest 238 
proportion (48.9%) of affected individuals presented clinical forms of stage 2 followed by stage 3 239 
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(45.2%). Stage-5 forms were rare (2.7%).  Mossy form was present in 66.1% and wounds in 26.7%. 240 
Only 35 (9.5%) of patients were found to have enlarged inguinal nodes. All lymphedema types 241 
were observed with the nodular being the most prevalent (59.0%) followed by mixed (26.3%) and 242 
water-bag (15.7%).  243 
Most patients (86.1%) complained of their legs suddenly becoming hot, red and painful with a 244 
frequency ranging from less often than a year (3.5%) to everyday (33.44%) (Table 5). Patients 245 
with stage 5 and 3 were the most affected with pains, 90% and 91% respectively compared to 246 
people with stage 2 and 4 (81.6% and 81.9% respectively). Regarding the influence of seasons on 247 
the intensity and frequency of leg pains, 61.6% of the patients declared that there was no difference 248 
between seasons while the rest said they felt pains during specific seasons (Table 4).  249 
 250 
 251 
 252 
 253 
 254 
  255 
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Table 4: Frequency and regional variation of acute attack experienced by podoconiosis 256 
patients and its associations with disease stage 257 
Variable  Number (%) 
Leg suddenly becoming hot, red and painful (N= 366)  
Yes 315(86.1) 
No 51(13.9) 
Frequency of acute attack (N= 311)   
Every day 104(33.44) 
Every week 75(24.11) 
Every two weeks 29(9.32) 
Every month 47(15.11) 
Every 03 months 23(7.39) 
Every 06 months 8(2.57) 
Less often than a year 11(3.53 
Every year 14(4.50) 
Acute attack with respect to disease stage   
Stage 2 146(81.6) 
Stage 3 152(91.0) 
Stage 4 9(81.9) 
Stage 5 9(90) 
Seasons associated with acute attack (N= 358)   
Cold and dry season 15(4.1) 
Cold and wet season 53(14.8) 
Hot and dry season 46(12.84) 
Hot and wet season 24(6.7) 
No difference by season 220(61.45) 
 258 
Assessment of socio-economic aspects of podoconiosis  259 
The majority (309, 96.5%) of the interviewees said they had worn shoes occasionally at some point 260 
in their life. The reportedly mean age at first shoe wearing was 14.2 ± 10.1, range (1-77 years). 261 
This mean age was significantly lower in women (12.4 ±8.2, range 1-50) than males (16.3 ±11.6, 262 
range 1-77), p< 0.001, Table 4. A high proportion (82.8%) of the participants wore shoes at the 263 
time of interview. Of those wearing shoes, only 67 (21.7%) were wearing protective shoes, among 264 
whom 53 were men (79.1%, 95% IC [69.36-88.8]) and 14 women (20.9%, IC [11.16-30.63], p< 265 
0.001, Table 6). Regarding the type of shoe, most participants (35.6%) reported they owned closed 266 
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leather shoes, followed by plastic shoes, tyre or rope sandals (23.8% for each) and closed plastic 267 
shoes (10.7%). Only 173 (46.2%) owned protective (enclosed) shoes, among whom 104 were men 268 
(62.7%, 95% IC [55.34-70.05]) and 62 women (37.3%, 95% IC [29.9-44.65], p< 0.001).  The 269 
majority of the participants reported wearing shoes during recreational activities and less 270 
frequently during household-related activities. Only a handful reported wearing shoes during farm-271 
related activities such as planting (21.4%), harvesting (19.0%) and working in a rice farm (17.9%) 272 
(Table 5). 273 
Table 5: Podoconiosis patients’ preventive social behaviours (Data obtained from a sub-274 
population). 275 
Variable Number (%) 
 Ever Owned Shoes 361 (96.5) 
 Age at first shoe wearing (N=352), Mean, (SD) 14.26 (10.1), range(1-77years) 
  Female 12.46 (8.2),  range (1-50 years) 
  Male 16.34 (11.6) range (1-77 Years) 
  Wearing shoes at interview 309 (82.8) 
 Wearing protective shoes at interview 67 (18.0) 
  Male 53 (79.1), 95% CI [69.36-88.8] 
  Female 14 (20.9), 95% CI [11.16-30.63] 
  Type of shoes declared   
  plastic sandals 89 (23.8) 
  Closed plastic shoes  40 (10.7) 
  Closed leather shoes  133 (35.6) 
  Tyre rope-made Sandals  89 (23.8) 
  Protective shoes (enclosed) 173 (46.2) 
  Male 104 (62.7), 95% CI [55.34-70.05] 
  Female 62 (37.3), 95% CI [29.9-44.65] 
 SHOE WEARING HABIT   
Recreational activities (%)   
Walking to market 323 (86.4)  
Going to Church 332 (88.8)  
Attending wedding 296 (79.1)  
Attending a funeral 306 (81.8)  
Village meeting 302 (80.7) 
House-related activities (%)  
18 
 
 
Working at home 188 (50.2)  
Fetching water 192 (51.3) 
Farm-related activities (%)   
Planting 80 (21.4)  
Harvesting 71 (19.0) 
  Working in a rice farm 67 (17.9) 
 276 
Monthly income was very low for people with stage 5 compared to people with other stages (Table 277 
6). The mean time lost due to pains potentially associated to their podoconiosis condition was 278 
estimated at 15.3 ± 49.3 days. The majority (71%) declared to lose 1-10 days when they feel pains 279 
while a minority said they could lose as many as 90 days. 280 
Table 6: Podoconiosis mean monthly income and income loss (Data obtained from a sub-281 
population). 282 
Variable Number (%) 
Mean monthly income (SD) in USD 28.33 (31.03) 
Time loss (days) when legs are paining (N= 252) 
mean (SD) 
15.3(49.3) 
Zero 15 (6.0) 
[1-2] 73 (29.0) 
[3-5] 48 (19.0) 
[6-10] 60 (23.0) 
[11-20] 14(5.6) 
[21-30] 30  (11.9) 
[31-90] 6 (2.4) 
Always paining 6 (2.4) 
Income by disease stage, Mean (SD) in USD   
2. 24.07 (23.6) 
3. 31.3 (34.7) 
4. 57.4 (53.6) 
5. 9.0 (3.5) 
Mean monthly income loss due to the disease per 
patient, Mean (SD) in USD 
 14.1 (50.9) 
 283 
 284 
 285 
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DISCUSSION 286 
The overall prevalence was estimated to be 0.49% ranging from 0.16-1.92% by Health District.  287 
Sex and age were identified to be risk factors for podoconiosis. The mean prevalence was far lower 288 
than that (8.1%) reported from two health districts in this region[10]. Higher prevalence rates have 289 
also been reported in Ethiopia [24-27] and in Uganda [28]. However, it is similar to the prevalence 290 
documented in Rwanda (0.6%) in the 1970s [4]. The low prevalence documented in the present 291 
study could be attributed to the fact that only podoconiosis stage 2 and above was identified. This 292 
decision was made to minimize the chance of false positives since the survey was carried out by 293 
CHIs who were not too familiar with podoconiosis. In a study conducted in Ethiopia, the 294 
proportion of patients with stage one disease was 16.7% [20]. It is worth mentioning that 295 
prevalence rates were presented per health district, so high prevalence rates in some health areas 296 
or communities may have been diluted out. Prevalence rates as high as 3% or more were recorded 297 
in some health areas of the Bafut, Bamenda and Batibo health districts, hence the need for control 298 
measures to be implemented in the region. This will also aid targeted interventions for priority 299 
areas within the region. 300 
The density map (Figure 4B) depicted heterogeneous distribution of podoconiosis in the region 301 
with the South (Bafut, Batibo, Njikwa, Mbengwi and Santa) being more affected than the North. 302 
Similar heterogeneous distribution of podoconiosis was observed in Ethiopia [11, 24]. The 303 
significant geographical variation in Ethiopia was said to be consistent with findings from 304 
individual studies and environmental characteristics studied [11, 24].  305 
The low prevalence registered in the younger individuals is in line with Desta’s work [6] and adds 306 
to the assumption long term environmental exposure to red clay soil is required for development 307 
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of the condition [4, 24, 29]. In our study, individuals aged >50 years were the most affected and 308 
were close to 8 times more likely to have the disease than younger individuals, and stage of disease 309 
increased with age.  310 
Women noticed first swelling earlier (mean age, 35 years) than men (mean age, 49 years). This 311 
might be the reason that females were more affected than males in the age group 40-50 years and 312 
males in the age group > 50 years. This could also account for the fact that the mean age people 313 
had lived with the disease was higher in women than men because the disease starts relatively 314 
earlier in women. The same observations have been made in Ethiopia [24]. 315 
 316 
The majority of patients were farmers, and most had no formal education. Most farmers work 317 
barefoot for hours including those working in swampy (rice-growing) areas. This behaviour is 318 
likely to expose them to the irritant particles thought to be implicated in triggering disease. Since 319 
they had little formal education, they are likely to be less informed about disease prevention than 320 
educated people, who were found to be less affected [24].  321 
Foot hygiene and shoe wearing so far remain the most important preventive measures against 322 
podoconiosis [30]. The majority (96.5%) of the study participants said they had worn shoes at least 323 
once in their lifetime. The prevalence of shoe wearing (82.8%) at the time of interview was far 324 
higher than that reported in Ethiopia [24, 31, 32]. This may in part explain the lower prevalence 325 
of podoconiosis in Cameroon. The mean age (14.26 years) at first shoe wearing was still relatively 326 
high. This means that a large proportion of the population started wearing shoes many years after 327 
birth, suggesting a long period of exposure to the environmental factors associated with the 328 
disease. Most participant said that they owned protective shoes, however, only a handful (67/374, 329 
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17.9%) wore them at the interview. The same observation has been made in Ethiopia [24]. People 330 
wore shoes mostly for recreational activities but rarely for the house- and farm-related activities 331 
during which they were most likely to be exposed to irritant particles. Men were found to wear 332 
protective shoes more than women.  333 
Eighty-six percent of the patients interviewed said their legs became hot, red and painful at least 334 
once a year. The mean time lost to such attacks was 15.3 ± 49.3 days, (range 1-90 days). Since 335 
patients usually cannot work during these attacks, there is loss of productivity. Patients in Ethiopia 336 
have been shown to lose close to 45% of their economically productive time due to morbidity 337 
associated with the disease [33].  338 
Over one third of interviewees had at least one relative with the condition. This is in line with 339 
previous studies. Family pedigrees collected in Ethiopia demonstrated high heritability, evidence 340 
for an autosomal co-dominant inheritance [6] and recent GWAS from an Ethiopian population 341 
indicated disease susceptibility associations in HLA class II region, chromosome 6 [7] though this 342 
has not yet been demonstrated in Cameroon.  343 
A major limitation of the study was its reliance on clinical examination, and the lack of a diagnostic 344 
test to rule out infectious-related causes of lymphoedema such as lymphatic filariasis. No 345 
parasitological or molecular technique was used to check for the presence of W. bancrofti. 346 
Nevertheless, previous parasitological, entomological and immunological studies in the region 347 
have revealed that lymphoedema cases found in the North West Cameroon are of non-filarial origin 348 
[8, 10, 33].  349 
Conclusions 350 
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Through this study, the geographical distribution of podoconiosis in North West region has been 351 
established in detail and the profile of disease, preventive behaviours and economic aspects 352 
assessed. The study has revealed a mean podoconiosis prevalence of 0.49%, ranging across health 353 
districts from 0.16% to 1.92%, with some health areas registering prevalence rates greater than 354 
3%. Age and sex were identified to be risk factors for the disease, women and older individuals 355 
were the most affected. Although the majority of participants said they possessed shoes, they wore 356 
them only occasionally. Podoconiosis-related morbidity was still a major problem for patients, 357 
leading to loss of working time and productivity. Awareness raising through education and 358 
sensitization will be invaluable in this setting to alleviate these multiple podoconiosis-related 359 
burdens.  360 
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